UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Kolon CEO arrested for mislabeling Invossa’s ingredient
by Jeong Sae-im
2020-02-03 15:34
Drug firms minimize gatherings, hospital visits as coronavirus fear spreads
by Jeong Sae-im
2020-02-03 15:21
Samsung BioLogics’ annual sales up 30% on contract research growth
by Jeong Sae-im
2020-01-23 14:47
MIT promotes industrial liaison program to Korean drugmakers
by Jeong Sae-im
2020-01-23 12:04
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months
by Jeong Sae-im
2020-01-21 11:43
라인
Korea’s botulinum toxin exports hit record high in 2019
by Jeong Sae-im
2020-01-20 11:38
Korea’s biopharma power shines at JP Morgan Healthcare meet
by Jeong Sae-im
2020-01-17 15:20
HLB stocks fall in after-hours trading due to interview on rivoceranib
by Jeong Sae-im
2020-01-16 15:46
[News Focus] Korean firms boast healthcare tech power at CES
by Jeong Sae-im
2020-01-14 11:45
[CES 2020] ‘Smoking disturbs sleep more than coffee does’
by Jeong Sae-im
2020-01-09 11:57
라인
[New Year Special] Natural stomach drugs get popular after ranitidine ban
by Jeong Sae-im
2020-01-07 16:12
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void
by Jeong Sae-im
2020-01-03 17:56
[New Year Special] Biotech rookies may shake up market cap rankings
by Jeong Sae-im
2020-01-02 14:31
Korea’s biopharmaceutical technology exports top ₩8 trillion won
by Jeong Sae-im
2019-12-30 15:26
Samsung BioLogics caught red-handed destroying evidence
by Jeong Sae-im
2019-12-28 12:17
라인
2nd rare cancer reported in Korea regarding Allergan’s breast implant
by Jeong Sae-im
2019-12-27 10:30
Local biopharmaceutical companies suffer from unsatisfactory P3 global trial results
by Jeong Sae-im
2019-12-27 07:06
Humedix wins patent on new anti-aging material
by Jeong Sae-im
2019-12-26 14:31
Regulator warns of serious breathing difficulties in gabapentinoid use
by Jeong Sae-im
2019-12-24 11:41
Vaxcell-Bio Therapeutics passes tech review for Kosdaq debut
by Jeong Sae-im
2019-12-23 15:42
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top